Insight

Kinetic Profiling

Sep 6, 2024, 09:54

Kinetic Profiling of RAS Mutations With Circulating Tumor DNA Suggests the Loss of RAS Mutations in Neo-RAS-Wildtype Metastatic Colorectal Cancer Is Transient

JCO Precision Oncology made the following post on X:

“Kinetic Profiling of RAS Mutations With Circulating Tumor DNA in the Canadian Cancer Trials Group CO.26 Trial Suggests the Loss of RAS Mutations in Neo-RAS-Wildtype Metastatic Colorectal Cancer Is Transient.”

Authors: Florence T.H. Wu, James T. Topham, Chris J. O’Callaghan, Harriet Feilotter, Hagen F. Kennecke, Leylah Drusbosky, Daniel J. Renouf, Derek J. Jonker, Dongsheng Tu, Eric X. Chen, Jonathan M. Loree.

Source: JCO Precision Oncology/X

Canadian Cancer Trials Group CO.26 Trial cancer Chris J. O'Callaghan Circulating tumor DNA Daniel J Renouf Derek J. Jonker Dongsheng Tu Eric X. Chen Florence T.H. Wu Hagen F.Kennecke Harriet Feilotter James T. Topham Jonathan M. Loree Leylah Drusbosky Metastatic colorectal cancer OncoDaily Oncology RAS mutations

Karen Knudsen: Better Together - Partnering to Accelerate Progress against Cancer

Sharon Osbourne and Colon Cancer: How She Went Against, How She Survived, and More

Marcia Cross and Anal Cancer: How She Went Against, How She Survived, and More

Pancreatic Cancer: Symptoms, Causes, Types, Diagnosis & Treatment

Former Disney CEO Bob Chapek Appointed Senior Adviser at SCAN Group

Special Coverage